A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy
Clinical trial NCT03029832 · TERMINATED
Trial details
- NCT number
- NCT03029832
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-27
- Primary completion
- 2018-04-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.